Nanjing, China

Laifang Zhang

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Shanghai Institute of Pharmaceutical Industry. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laifang Zhang. Retrieved from https://idiyas.com/inventor/laifang-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Laifang Zhang: Innovator in Pharmaceutical Crystallization

Introduction

Laifang Zhang is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the area of crystallization. His work focuses on enhancing the stability and solubility of pharmaceutical compounds.

Latest Patents

Laifang Zhang holds a patent for "Crystals of prasugrel hydrobromate." This patent discloses crystals of 2-acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrobromate, along with crystal compositions and pharmaceutical compositions that include them. The crystals of prasugrel hydrobromate possess excellent stability and solubility, making them valuable in pharmaceutical applications.

Career Highlights

Throughout his career, Laifang Zhang has worked with prominent organizations such as the Shanghai Institute of Pharmaceutical Industry and Chia Tai Tianqing Pharmaceutical Group Co., Ltd. His experience in these institutions has contributed to his expertise in pharmaceutical innovations.

Collaborations

Laifang Zhang has collaborated with notable colleagues, including Zhedong Yuan and Xingdong Cheng. Their combined efforts have further advanced research in the pharmaceutical field.

Conclusion

Laifang Zhang's contributions to pharmaceutical crystallization demonstrate his commitment to innovation and excellence in the industry. His work continues to impact the development of effective pharmaceutical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…